Kaveri Pohlman
Stock Analyst at Clear Street
(2.77)
# 1,561
Out of 5,150 analysts
34
Total ratings
32.26%
Success rate
3.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Downgrades: Hold | $60 → $58 | $58.01 | -0.02% | 3 | Jan 20, 2026 | |
| JANX Janux Therapeutics | Downgrades: Hold | $32 → $12 | $14.35 | -16.38% | 3 | Jan 20, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $12 | $1.74 | +589.66% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $63.13 | +56.82% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $135.49 | +47.61% | 1 | Dec 5, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $13.96 | +79.08% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $12.92 | +62.54% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $6.99 | +157.51% | 1 | Nov 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Buy | $29 | $5.76 | +403.47% | 1 | Oct 22, 2025 | |
| VTYX Ventyx Biosciences | Initiates: Buy | $11 | $14.00 | -21.43% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $34.99 | +31.47% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $26.56 | +20.48% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.08 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $28.18 | +66.78% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $16.30 | +84.05% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $12.74 | +198.27% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $4.74 | +5.49% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.49 | +436.91% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $41.69 | -35.24% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $22.68 | +208.64% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.73 | +153.70% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $5.07 | +57.79% | 2 | Jul 7, 2022 |
RAPT Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $60 → $58
Current: $58.01
Upside: -0.02%
Janux Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $32 → $12
Current: $14.35
Upside: -16.38%
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $1.74
Upside: +589.66%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $63.13
Upside: +56.82%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $135.49
Upside: +47.61%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $13.96
Upside: +79.08%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $12.92
Upside: +62.54%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $6.99
Upside: +157.51%
Sagimet Biosciences
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $5.76
Upside: +403.47%
Ventyx Biosciences
Oct 1, 2025
Initiates: Buy
Price Target: $11
Current: $14.00
Upside: -21.43%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $34.99
Upside: +31.47%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $26.56
Upside: +20.48%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.08
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $28.18
Upside: +66.78%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $16.30
Upside: +84.05%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $12.74
Upside: +198.27%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $4.74
Upside: +5.49%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.49
Upside: +436.91%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $41.69
Upside: -35.24%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $22.68
Upside: +208.64%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $4.73
Upside: +153.70%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $5.07
Upside: +57.79%